How long do you need to stay on Wegovy — and what happens when you stop?

Why there is no standard answer to how long you stay on Wegovy

The most common misconception our prescribers hear is that Wegovy is a short course, a few months to kick-start things, then done. That picture is understandable, but it does not match how the medicine works or what the evidence says.

Semaglutide acts on the appetite-regulating pathways in the brain and slows gastric emptying. These effects are present while you are taking it; they fade when you stop. The STEP 1 trial demonstrated this clearly: participants who had lost roughly 15% of their body weight over 68 weeks regained the majority of it within 12 months of stopping. That is not a failure of willpower, it reflects the biology of a chronic condition, not a temporary one.

So when people ask how long they need to stay on Wegovy, the honest clinical answer is: for as long as the benefits continue to outweigh the risks, as judged by your prescriber. For some people that is two years; for others, ongoing treatment makes clinical sense well beyond that. What it rarely is, on the evidence available, is a six-week fix.

If you are curious about how quickly results typically arrive in the first place, the timeline for Wegovy to take effect is worth reading first before thinking about the end point.

What the two-year NHS limit actually means for you

NICE recommends semaglutide (Wegovy) for NHS use for a maximum of two years, delivered within a specialist weight management service with multidisciplinary support. If less than 5% weight loss has occurred after six months at the maintenance dose, NICE guidance suggests reassessing whether treatment should continue.

That two-year ceiling applies to NHS commissioning. It does not automatically define what is medically appropriate for every individual, and it does not govern private prescribing. A private prescriber reviewing your case (as ours do before every repeat order) can assess the clinical picture and support continued treatment where the benefit remains clear and the safety profile is acceptable.

NHS access to Wegovy currently runs through specialist services, which often carry long waiting lists. Where to access Wegovy in the UK explains the difference between the NHS and private routes in more detail, including what to look for in a regulated online pharmacy. It is worth reading if you are weighing up your options.

What matters practically: the two-year figure is not a sign that Wegovy stops working at month 24. It reflects how NICE modelled cost-effectiveness for NHS commissioning. The underlying biology does not reset on a calendar.

Factors that genuinely shape how long treatment lasts

Several things influence whether staying on Wegovy longer makes sense for you specifically. Your prescriber will weigh most of these at each clinical review.

How much weight you have lost and whether you have reached a plateau. Some people reach a stable lower weight and maintain it comfortably; others find that stopping brings rapid regain. Neither outcome is guaranteed.

Whether you have a weight-related health condition. If Wegovy was prescribed partly because of high blood pressure, type 2 diabetes, or another comorbidity, the clinical case for continuing may be stronger than for someone treating weight alone. The realistic timelines for specific weight targets can help put your own progress in context.

How well you are tolerating it. Most side effects are gastrointestinal (nausea, changes in bowel habit, occasional reflux) and tend to settle after the first weeks or following a dose increase. Long-term tolerability is generally good in trial populations, though individual experiences vary.

Your own goals and preferences. Some people reach a weight where they feel confident managing without the medicine; others want to continue and have a clinical case for doing so. That conversation belongs with your prescriber, not a checklist.

The minimum realistic duration on Wegovy is also covered separately for people wondering about the other end of the question.

What clinical review at each stage actually looks like

Continuing treatment is not automatic. At nume, a GPhC-registered prescriber reads your case before every repeat, your weight, your progress, any symptoms you have reported, and whether the treatment picture still makes clinical sense. This is not a box-ticking exercise; it is the kind of oversight that makes ongoing prescribing responsible.

The NHS England guidance on weight-management injections sets out the clinical expectation that decisions about continuing or stopping are reviewed regularly, not locked in at the start. Our clinical team follows the same principle: treatment continues when it should, and stops when it should.

If you are thinking about how duration fits into your wider treatment plan, the full Wegovy overview covers the medicine's licensed use, the evidence behind it, and what private prescribing involves. And if you have a specific question not answered here, our prescribers are available through aftercare support seven days a week.

Ready to explore whether treatment is right for you? Check your eligibility with a free consultation, reviewed the same day by a real prescriber, not an automated process.